July 2017, study entitled “Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease” was published in the Journal of Allergy and Clinical Immunology. This article was highlighted in the journal’s Editor’s Choice feature.

August 2017, study entitled “Leukotriene C4 potentiates IL-33-induced group 2 innate lymphoid cell activation and lung inflammation” was published in the Journal of Immunology.

May 2011, study entitled “The tumor necrosis factor family member LIGHT is a target for asthmatic airway remodeling” was published in Nature Medicine.

Funding for the Doherty lab has been provided by: The National Institute of Allergy and Infectious Disease (NIAID), the American Lung Association (ALA), the American Academy of Allergy, Asthma, and Immunology (AAAAI), and UCSD CTRI.